Ifidancitinib

CAS No. 1236667-40-5

Ifidancitinib( —— )

Catalog No. M35053 CAS No. 1236667-40-5

Ifidancitinib (ATI-50002) is a specific JAK kinase 1/3 inhibitor that induces hair growth in AA-affected C3H/HeJ mice.Ifidancitinib can be used to study autoimmune diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 226 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Ifidancitinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Ifidancitinib (ATI-50002) is a specific JAK kinase 1/3 inhibitor that induces hair growth in AA-affected C3H/HeJ mice.Ifidancitinib can be used to study autoimmune diseases.
  • Description
    Ifidancitinib (ATI-50002) is a potent and selective inhibitor of JAK kinases 1/3. Ifidancitinib can be used in studies of allergies, asthma and autoimmune diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    JAK
  • Recptor
    JAK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1236667-40-5
  • Formula Weight
    395.39
  • Molecular Formula
    C20H18FN5O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 62.5 mg/mL (158.07 mM; Ultrasonic )
  • SMILES
    COc1cc(Nc2ncc(C)c(Nc3ccc4oc(=O)[nH]c4c3)n2)cc(C)c1F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li, Hui; Heckrodt, Thilo J.; Chen, Yan; Mcmurtrie, Darren John; Taylor, Vanessa; Singh, Rajinder; Ding, Pingyu; Yen, Rose.Preparation of phenylaminopyrimidinylaminooxobenzooxazole derivatives for use as JAK kinase inhibitors. WO2012015972A1
molnova catalog
related products
  • PF-03084014

    PF-03084014 (PF-3084014) is a specific γ-secretase inhibitor (IC50: 6.2 nM, in a cell-free assay).

  • BMS-911543

    A potent and selective small-molecule inhibitor of JAK2 with IC50 of 1.1 nM.

  • PF-06700841

    PF-06700841 is a potent, selective TYK2/JAK1 kinase inhibitor that reduces IL-23 expression and directly attenuates IL-23 signaling via TYK2.